“…The seriousness of the disease prompted several research groups to work on the development of new antileishmanial agents and the class of scaffolds explored includes various quinolines, [10–13] chalcones, [14,15] nitroimidazole, [16] triazolopyrimidine, [17] pyrazolopyrimidine, [18,19] aminopyrazole, [20] triazine, [21,22] quinazoline, [23] thymidine, [24] triterpenoids, [25] and quinazolinone [26] . The isolation and synthesis of a new class of biaryl naphthylisoquinoline alkaloid ancistroealaine A ( 1a ) from Ancistrocladus ealaensis and other alkaloids ( 1b , 1c ), and their antileishmanial activity has generated interest in the development of new antileishmanial agents [27–29] .…”